Empagliflozin and dapagliflozin, sodium glucose cotransporter 2 inhibitors, may improve cognitive dysfunctions: in silico and in vivo findings

Authors: Humeysa Kiyak-Kirmaci, Ayse Nur Hazar-Yavuz, Elif Beyzanur Polat et al.
Publication: Behavioural Brain Research
Published: May 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Pharmacological evaluation of betulinic acid in sodium valproate-induced autism spectrum disorder in rat pups

Kanika Pasrija, Ramachandran Subramaniam et al. - Nov 2026

Read More
Sodium alginate-based photothermal film: preparation, antibacterial activity, and application for preservation of Kyoho grapes

Zihan Hou, Yunxiao Xia et al. - Nov 2026

Read More
Transformation of organic matter and mineral composition of tournaisian oil deposits and Domanic shale under hydrothermal conditions in the presence of sodium nanoparticles

Liliya Kh. Galiakhmetova, Vladimir E. Katnov et al. - Oct 2026

Read More
Air sensitivity of layered oxides for practical sodium-ion batteries

Xin-Yang Zhou, Zhi-Xiong Huang et al. - Oct 2026

Read More
Ultrafine grinding and multi-stage flotation of coal to ultra-low ash precursor for high-performance hard carbon anodes in sodium-ion batteries

Fan Li, Xiaomin Ma et al. - Oct 2026

Read More